Vera Elsa, Blasco Maria A
Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, E-28029, Spain.
Aging (Albany NY). 2012 Jun;4(6):379-92. doi: 10.18632/aging.100462.
The length of telomeres, and in particular the abundance of short telomeres, has been proposed as a biomarker of aging and of general health status. A wide variety of studies show the association of short telomeres with age related pathologies and cancer, as well as with lifespan and mortality. These facts highlight the importance of measuring telomere length in human populations and by using reliable methods to uncover the association between telomere length and human disease. This review discusses the advantages and drawbacks of current telomere length measurement methods. Most of these methods provide mean telomere length values per cell or per sample and very few of them are able to measure the abundance of short telomeres, which are the ones indicative of telomere dysfunction. The information provided by each method and their suitability for different studies is discussed here.
端粒长度,尤其是短端粒的丰度,已被提议作为衰老和总体健康状况的生物标志物。大量研究表明短端粒与年龄相关疾病、癌症以及寿命和死亡率之间存在关联。这些事实凸显了在人群中测量端粒长度以及使用可靠方法揭示端粒长度与人类疾病之间关联的重要性。本综述讨论了当前端粒长度测量方法的优缺点。这些方法大多提供每个细胞或每个样本的平均端粒长度值,其中很少有方法能够测量短端粒的丰度,而短端粒是表明端粒功能障碍的指标。本文将讨论每种方法所提供的信息及其对不同研究的适用性。